With their ability to activate the p38 MAPK and ERK1/ERK2 signaling pathways, PMN‐MDSCs can upregulate VEGF and CXCR expression in tumor cells,146 inducing proangiogenic effects and facilitating angiogenesis.147. This evidence concerns the gene MAPK1 and neoplasm.